DNA Methylation Biomarkers as Prediction Tools for Therapeutic Response and Prognosis in Intermediate-Stage Hepatocellular Carcinoma.

Lu, Chang-Yi; Hsiao, Chih-Yang; Peng, Pey-Jey; Huang, Shao-Chang; Chuang, Meng-Rong; Su, Hung-Ju; Huang, Kai-Wen.

Afiliação

Lu CY; Phalanx Biotech Group, Hsinchu 300, Taiwan.
Hsiao CY; Department of Surgery and Hepatitis Research Center, National Taiwan University Hospital, Taipei 100, Taiwan.
Peng PJ; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Huang SC; Department of Traumatology, National Taiwan University Hospital, Taipei 100, Taiwan.
Chuang MR; Phalanx Biotech Group, Hsinchu 300, Taiwan.
Su HJ; Phalanx Biotech Group, Hsinchu 300, Taiwan.
Huang KW; Phalanx Biotech Group, Hsinchu 300, Taiwan.

Cancers (Basel) ; 15(18)2023 Sep 07.

Article em En | MEDLINE | ID: mdl-37760434